Abarelix - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for abarelix and what is the scope of freedom to operate?
Abarelix
is the generic ingredient in one branded drug marketed by Speciality European and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for abarelix
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 45 |
Clinical Trials: | 2 |
Patent Applications: | 7,372 |
DailyMed Link: | abarelix at DailyMed |
Recent Clinical Trials for abarelix
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
PRAECIS Pharmaceuticals Inc. | Phase 2 |
Speciality European Pharma Limited | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for abarelix
US Patents and Regulatory Information for abarelix
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Speciality European | PLENAXIS | abarelix | INJECTABLE;INTRAMUSCULAR | 021320-001 | Nov 25, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for abarelix
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Speciality European | PLENAXIS | abarelix | INJECTABLE;INTRAMUSCULAR | 021320-001 | Nov 25, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Speciality European | PLENAXIS | abarelix | INJECTABLE;INTRAMUSCULAR | 021320-001 | Nov 25, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Speciality European | PLENAXIS | abarelix | INJECTABLE;INTRAMUSCULAR | 021320-001 | Nov 25, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Speciality European | PLENAXIS | abarelix | INJECTABLE;INTRAMUSCULAR | 021320-001 | Nov 25, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Speciality European | PLENAXIS | abarelix | INJECTABLE;INTRAMUSCULAR | 021320-001 | Nov 25, 2003 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |